AminoVault expands U.S.-made research product lines

AminoVault said Aug. 24 it is expanding its U.S.-manufactured research catalog with high-purity materials for qualified laboratories and preclinical studies. The move leans on testing, batch documentation and strict research-use limits as the company broadens its peptide and blend offerings.

Why it matters: - AminoVault is trying to position itself as a stricter, more transparent supplier in the research materials market. - The expansion is aimed at qualified researchers and laboratories that need materials with defined specifications, analytical testing and batch-level documentation. - The company’s research-use restrictions are meant to reduce confusion between laboratory products and consumer or medical products.

What happened: - AminoVault announced the continued expansion of its U.S.-manufactured research product lines on Aug. 24, 2026, in San Diego. - The company said the expanded catalog includes individual research peptides, specialized research blends and other laboratory materials manufactured to defined specifications. - AminoVault said every product is intended exclusively for legitimate laboratory, analytical and preclinical research. - The company said its product information is limited to research-relevant details, including material identity, quantity, format, analytical specifications, storage requirements and available laboratory documentation.

The details: - The individual research lineup includes BPC-157, TB-500, KPV, GHK-Cu, MOTS-C, Sermorelin, Tesamorelin, Ipamorelin, CJC-1295, Selank, Semax, Epithalon, Thymosin Alpha-1, ARA-290, IGF-1 LR3 and other compounds. - AminoVault also offers multi-component research formulations, including KLOW, which contains KPV, BPC-157, TB-500 and GHK-Cu. - The company said product availability, concentrations and configurations may change as manufacturing capabilities evolve and research needs shift. - AminoVault works with U.S.-based manufacturing partners to produce research materials according to defined specifications. - Products are evaluated with analytical methods to verify identity, composition and purity. - The quality-control process may include high-performance liquid chromatography testing, mass-spectrometry analysis, third-party laboratory verification, heavy-metal or endotoxin screening when applicable, and controlled packaging and handling. - AminoVault makes Certificates of Analysis and related documentation available when provided for an applicable product or batch. - The company says its products are marked for research use only and not for human or animal use. - AminoVault says its products are not intended for consumption, injection, administration, compounding, diagnostic procedures or therapeutic applications. - The company does not provide dosing recommendations, treatment protocols, administration guidance or individualized medical advice.

Between the lines: - The expansion looks designed to build trust through documentation and tighter product controls, not just by adding more inventory. - AminoVault is also drawing a hard line around how its products can be described and sold, which may help limit regulatory or customer-use confusion. - Founder Jake Bastien said the company wants to raise expectations for quality and transparency in the research supply industry. - Bastien said U.S. manufacturing and responsible product communication are central to how AminoVault is building the business. - The company said references to a compound’s scientific identity or published research do not amount to a claim of safety, efficacy or suitability for a specific application. - AminoVault said research findings about a compound should not be interpreted as evidence that its products are approved for medical or consumer use.

What's next: - AminoVault said future catalog additions will remain subject to its standards for manufacturing, analytical evaluation, documentation and responsible presentation. - The company said it will continue reviewing its catalog, website content and product descriptions to keep public communications consistent with the designated purpose of the products. - AminoVault also said it may restrict or refuse transactions that appear inconsistent with legitimate research use. - The company said more information about its research catalog and available Certificates of Analysis is available here.

The bottom line: - AminoVault is expanding its research catalog while pairing growth with stricter testing, documentation and use-limit messaging.